StoneX Reiterates Buy Rating on DexCom, Inc. (DXCM)

Market Context

DexCom, Inc. operates in the Healthcare sector. The stock currently trades at $82.43 with a market capitalization of $27.0B. The stock has gained 14.4% over the past 52 weeks.

Analyst coverage from StoneX provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DexCom, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for DexCom, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 30, 2026	Barclays	Overweight	N/A
Oct 30, 2026	StoneX	Buy	N/A
Oct 12, 2026	BTIG	Buy	N/A
Oct 07, 2026	Barclays	Overweight	N/A
Oct 01, 2026	RBC Capital	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View DXCM Stock Page